Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionAsset Dedication, LLC
Latest Disclosed Ownership328 shares
Latest Disclosed Value $ 50,102
Asset Dedication, LLC reports 23.36% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 29, 2026 - Asset Dedication, LLC filed a 13F-HR form disclosing ownership of 328 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $50,102 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 428 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -23.36% during the quarter. The current value of the position is $47,120 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 328 -100 -23.36 50 -15.25 0.0035
2026-01-26 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 428 100 30.49 59 40.48 0.0039
2025-11-20 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 328 5 1.55 42 7.69 0.0028
2025-08-19 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 323 0 0.00 39 8.33 0.0028
2025-05-01 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 323 20 6.60 36 24.14 0.0029
2025-01-23 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 303 0 0.00 29 -14.71 0.0023
2024-10-15 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 303 0 0.00 35 6.25 0.0024
2024-08-06 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 303 0 0.00 32 0.0022
2024-04-16 2024-03-31 13F Novartis AG ADR Equities 66987V109 303 0 0.00 0 0.0022
2024-02-08 2023-12-31 13F Novartis AG ADR Equities 66987V109 303 0 0.00 0 0.0024
2023-11-13 2023-09-30 13F Novartis AG ADR Equities 66987V109 303 0 0.00 0 0.0026
2023-08-22 2023-06-30 13F Novartis AG ADR Equities 66987V109 303 0 0.00 0 0.0026
2023-04-24 2023-03-31 13F Novartis AG ADR Equities 66987V109 303 0 0.00 0 0.0026
2023-01-19 2022-12-31 13F Novartis AG ADR Equities 66987V109 303 107 54.59 0 -100.00 0.0028
2022-10-27 2022-09-30 13F Novartis AG ADR Equities 66987V109 196 0 0.00 15 -11.76 0.0016
2022-07-19 2022-06-30 13F Novartis AG ADR Equities 66987V109 196 0 0.00 17 0.00 0.0025
2022-04-21 2022-03-31 13F Novartis AG ADR Equities 66987V109 196 -224 -53.33 17 -52.78 0.0019
2022-01-21 2021-12-31 13F Novartis AG ADR Equities 66987V109 420 -260 -38.24 36 -33.33 0.0043
2021-10-18 2021-09-30 13F Novartis AG ADR Equities 66987V109 680 0 0.00 54 -11.48 0.0071
2021-07-21 2021-06-30 13F Novartis AG ADR Equities 66987V109 680 0 0.00 61 3.39 0.0091
2021-05-03 2021-03-31 13F Novartis AG ADR Equities 66987V109 680 400 142.86 59 118.52 0.0133
2021-01-28 2020-12-31 13F Novartis AG ADR Equities 66987V109 280 0 0.00 27 8.00 0.0054
2020-10-20 2020-09-30 13F Novartis AG ADR Equities 66987V109 280 0 0.00 25 0.00 0.0055
2020-08-24 2020-06-30 13F Novartis AG ADR Equities 66987V109 280 0 0.00 25 8.70 0.0068
2020-05-05 2020-03-31 13F Novartis AG ADR Equities 66987V109 280 -87 -23.71 23 -34.29 0.0068
2020-01-31 2019-12-31 13F Novartis AG ADR Equities 66987V109 367 87 31.07 35 40.00 0.0099
2019-10-17 2019-09-30 13F Novartis AG ADR Equities 66987V109 280 -24 -7.89 25 -7.41 0.0083
2019-07-23 2019-06-30 13F Novartis AG ADR Equities 66987V109 304 151 98.69 27 80.00 0.0087
2019-04-19 2019-03-31 13F Novartis AG ADR Equities 66987V109 153 0 0.00 15 7.14 0.0052
2019-02-12 2018-12-31 13F Novartis AG ADR Equities 66987V109 153 0 0.00 14 0.00 0.0057
2018-10-26 2018-09-30 13F Novartis AG ADR Equities 66987V109 153 0 0.00 14 27.27 0.0053
2018-08-13 2018-06-30 13F Novartis AG ADR Equities 66987V109 153 -75 -32.89 11 -38.89 0.0038
2018-04-19 2018-03-31 13F Novartis AG ADR Equities 66987V109 228 210 1,166.67 18 800.00 0.0089
2018-01-17 2017-12-31 13F Novartis AG ADR Equities 66987V109 18 18 2 0.0008
2017-01-17 2016-12-31 13F Novartis A G Spon Adr Equities 66987V109 0 -26 -100.00 0 -100.00
2016-10-19 2016-09-30 13F Novartis A G Spon Adr Equities 66987V109 26 0 0.00 2 0.00 0.0015
2016-07-14 2016-06-30 13F Novartis A G Spon Adr Equities 66987V109 26 0 0.00 2 0.00 0.0015
2016-04-27 2016-03-31 13F Novartis A G Spon Adr Equities 66987V109 26 0 0.00 2 0.00 0.0015
2016-02-16 2015-12-31 13F Novartis A G Spon Adr EQUITIES 66987V109 26 26 2 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.